Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA litargirio warning

This article was originally published in The Tan Sheet

Executive Summary

Consumers should immediately stop all use of litargirio powder, which may be found in deoderant, foot fungicide and burn and wound treatment products, 1FDA announces Oct. 2. Agency is working with the Consumer Product Safety Commission to alert public to risks of lead poisoning after ingestion or contact with skin. Powder is a traditional remedy popular in the Dominican Republic that does not have any proven health benefits and is particularly harmful to children, agency points out. Rhode Island Department of Health alerted FDA to product's dangers after several children using litargirio as deoderant were treated for lead poisoning...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel